Skip to main content
RLAY filings

Corporate insider profile

Donald A Bergstrom Filing Activity

Latest reported as President, R&D of Relay Therapeutics, Inc. (RLAY).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,808,840.91
Latest transaction
Jul 28, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 28, 2026Relay Therapeutics, Inc. (RLAY)President, R&DSale2,237$18.61$41,631
Jul 6, 2026Relay Therapeutics, Inc. (RLAY)President, R&DSale8,660$18.71$162,029
Jun 22, 2026Relay Therapeutics, Inc. (RLAY)President, R&DSale93,456$16.94$1,583,145